Dr. Adrian Harry Shandling, MD

Dr. Shandling practices at Cardiovascular Care Inc in Los Alamitos, California.

Dr. Shandling's NPI, 1386640522, was assigned on June 22, 2005. Dr. Shandling graduated from University of Cape Town Faculty of Medicine in 1979. Dr. Shandling holds California license A41635.

Dr. Shandling's primary practice is Cardiovascular Care Inc, at 3801 Katella Ave, Los Alamitos, CA 90720 in Orange County. The practice phone is (562) 598-3200.

Dr. Shandling's primary practice is Cardiovascular Care Inc in Los Alamitos, California. Dr. Shandling is also affiliated with UCI Health - Orange. The medical group on file is Cardiovascular Care Associates. Dmand AI also links Dr. Shandling to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shandling practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Shandling's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Shandling is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Shandling is licensed in California.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy and cerebrovascular disease among the conditions Dr. Shandling treats.

CMS data shows 17,485 Medicare services from Dr. Shandling across 64 procedure codes in 2024, for 835 Medicare patients. Medicare paid $751,393 for them.

CMS counts 835 Medicare patients who saw Dr. Shandling in 2024. The largest group is 75 to 84, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shandling's median patient age at 76, with 50% women.

In 2024, Dr. Shandling wrote 9,294 Medicare Part D claims for 650 patients. 85% of them were for generic drugs. CMS names the drug for 8,600 of them, across 128 drugs with 11 or more claims each, at $1,620,052 in total drug cost. In 2023, CMS named 8,085 claims across 121 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Shandling for performance year 2024, reported as part of a group. Dr. Shandling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shandling as offering telehealth.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 29 papers to Dr. Shandling, published from 2009 to 2021. 2021 was the busiest year, with 2. The most frequent topics are Electrocardiography, Pacemaker, Artificial and Coronary Disease. Dr. Shandling has published most often in Pacing Clin Electrophysiol. Dr. Shandling's most frequent co-authors are Robert Detrano, MD, Mark Y. Lee, MD and Daniel Edwin Rieders, MD.

Dmand AI links Dr. Shandling to 1 clinical trial. Conditions studied include Atrial Fibrillation and Arrhythmias, Cardiac.

CMS Open Payments shows 1,648 general payments to Dr. Shandling from 72 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Medtronic Vascular, Inc. paid the most, $3,226.

Dmand AI lists 5 awards for Dr. Shandling, most recently Top Doctors:LA Area in 2013.

Dr. Shandling graduated from University of Cape Town Faculty of Medicine in 1979. Dr. Shandling is a member of ACC.

Dr. Shandling is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.